Note payable to DIRECTV
Neurocrine Biosciences Note payable to DIRECTV decreased by 15.1% to $58.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.1%, from $47.70M to $58.70M. Over 5 years (FY 2020 to FY 2025), Note payable to DIRECTV shows an upward trend with a 31.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase suggests higher short-term debt reliance, while a decrease indicates the company is successfully paying down specific contractual obligations.
Detailed definition
This represents a short-term financial obligation owed to a specific corporate entity, categorized as a current liabilit...
Peer comparison
Similar to other 'Notes Payable' or 'Accounts Payable to Related Parties' found in the current liabilities section of peer balance sheets.
note_payable_directvHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $22.00M | $20.00M | $20.00M | $17.60M | $20.00M | $18.10M | $20.70M | $18.40M | $21.20M | $18.70M | $35.90M | $36.70M | $40.00M | $37.00M | $46.10M | $47.70M | $56.80M | $53.70M | $69.10M | $58.70M |
| QoQ Change | — | -9.1% | +0.0% | -12.0% | +13.6% | -9.5% | +14.4% | -11.1% | +15.2% | -11.8% | +92.0% | +2.2% | +9.0% | -7.5% | +24.6% | +3.5% | +19.1% | -5.5% | +28.7% | -15.1% |
| YoY Change | — | — | — | — | -9.1% | -9.5% | +3.5% | +4.5% | +6.0% | +3.3% | +73.4% | +99.5% | +88.7% | +97.9% | +28.4% | +30.0% | +42.0% | +45.1% | +49.9% | +23.1% |
Note payable to DIRECTV at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's note payable to directv?
- Neurocrine Biosciences (NBIX) reported note payable to directv of $58.70M in Q1 2026.
- How has Neurocrine Biosciences's note payable to directv changed year-over-year?
- Neurocrine Biosciences's note payable to directv increased by 23.1% year-over-year, from $47.70M to $58.70M.
- What is the long-term trend for Neurocrine Biosciences's note payable to directv?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's note payable to directv has grown at a 31.2% compound annual growth rate (CAGR), from $17.80M to $69.10M.
- What does note payable to directv mean?
- A short-term debt obligation owed to a specific business partner or related entity.